Sort

Search

17/10/2022 Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjogren's syndrome: A critical review
Vilchez-Oya, F, Martin, HB, Garcia-Martinez, E, Corominas, H. Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjogren's syndrome: A critical review. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.1003054. PMID:36325321. IF:7.300(Q1/3D).
15/10/2022 GlycA and GlycB as Inflammatory Markers in Chronic Heart Failure
Cediel, G, Teis, A, Codina, P, Julve, J, Domingo, M, Santiago-Vacas, E, Castelblanco, E, Amigo, N, Lupon, J, Mauricio, D, Alonso, N, Bayes-Genis, A. GlycA and GlycB as Inflammatory Markers in Chronic Heart Failure. AMERICAN JOURNAL OF CARDIOLOGY. 2022; 181DOI:10.1016/j.amjcard.2022.07.019. PMID:36008162. IF:2.800(Q3/6D).
11/10/2022 Muscle MRI in McArdle Disease A European Multicenter Observational Study
Lokken, N, Revsbech, KL, Jacobsen, LN, Martinuzzi, A, Martin, MA, Diaz-Manera, J, Dominguez-Gonzalez, C, Brondani, G, Musumeci, O, Granata, F, Stefan, C, Merino-Sanchez, C, Peralta, CN, Khawajazada, T, Alonso-Perez, J, Toscano, A, Vissing, J. Muscle MRI in McArdle Disease A European Multicenter Observational Study. NEUROLOGY. 2022; 99(15)DOI:10.1212/WNL.0000000000200914. PMID:35853747. IF:9.900(Q1/1D).
11/10/2022 Prevalence of sexual harassment among young Spaniards before, during, and after the COVID-19 lockdown period in Spain
Casanovas, LVL, Serra, L, Canals, CS, Sanz-Barbero, B, Vives-Cases, C, Lopez, MJ, Otero-Garcia, L, Perez, G, Renart-Vicens, G. Prevalence of sexual harassment among young Spaniards before, during, and after the COVID-19 lockdown period in Spain. BMC PUBLIC HEALTH. 2022; 22(1)DOI:10.1186/s12889-022-14264-9. PMID:36221078. IF:4.500(Q2/4D).
11/10/2022 Association of alpha-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitus
Castelblanco, E, Hernandez, M, Alonso, N, Ribes-Betriu, A, Real, J, Granado-Casas, M, Rossell, J, Rojo-Lopez, MI, Dusso, AS, Julve, J, Mauricio, D. Association of alpha-klotho with subclinical carotid atherosclerosis in subjects with type 1 diabetes mellitus. Cardiovascular Diabetology. 2022; 21(1)DOI:10.1186/s12933-022-01640-3. PMID:36221075. IF:9.300(Q1/1D).
10/10/2022 COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer
Herbst, RS, Majem, M, Barlesi, F, Carcereny, E, Chu, Q, Monnet, I, Sanchez-Hernandez, A, Dakhil, S, Camidge, DR, Winzer, L, Soo-Hoo, Y, Cooper, ZA, Kumar, R, Bothos, J, Aggarwal, C, Martinez-Marti, A. COAST: An Open-Label, Phase II, Multidrug Platform Study of Durvalumab Alone or in Combination With Oleclumab or Monalizumab in Patients With Unresectable, Stage III Non-Small-Cell Lung Cancer. JOURNAL OF CLINICAL ONCOLOGY. 2022; 40(29)DOI:10.1200/JCO.22.00227. PMID:35452273. IF:45.300(Q1/1D).
05/10/2022 Women's values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review
Leon-Garcia, M, Humphries, B, Maraboto, A, Rabassa, M, Boehmer, KR, Perestelo-Perez, L, Xie, F, Pelayo, I, Eckman, M, Bates, S, Selva, A, Alonso-Coello, P. Women's values and preferences on low-molecular-weight heparin and pregnancy: a mixed-methods systematic review. BMC Pregnancy and Childbirth. 2022; 22(1)DOI:10.1186/s12884-022-05042-x. PMID:36199014. IF:3.100(Q2/4D).
04/10/2022 How Reliable Is Endoscopic Stone Recognition? A Comparison Between Visual Stone Identification and Formal Stone Analysis
Henderickx, MMEL, Stoots, SJM, De Bruin, DM, Wijkstra, H, Freund, JE, Wiseman, OJ, Ploumidis, A, Skolarikos, A, Somani, BK, Sener, TE, Emiliani, E, Dragos, LB, Villa, L, Talso, M, Daudon, M, Traxer, O, Kronenberg, P, Doizi, S, Tailly, T, Tefik, T, Hendriks, N, Beerlage, HP, Baard, J, Kamphuis, GM. How Reliable Is Endoscopic Stone Recognition? A Comparison Between Visual Stone Identification and Formal Stone Analysis. JOURNAL OF ENDOUROLOGY. 2022; 36(10)DOI:10.1089/end.2022.0217. PMID:35651279. IF:2.700(Q2/5D).